Toward understanding and exploiting tumor heterogeneity

[1]  Ash A. Alizadeh,et al.  Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers , 2015 .

[2]  Beatriz Bellosillo,et al.  Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients , 2015, Nature Medicine.

[3]  Charles Swanton,et al.  Clinical management of breast cancer heterogeneity , 2015, Nature Reviews Clinical Oncology.

[4]  Troy Guthrie,et al.  Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Allon M. Klein,et al.  Droplet Barcoding for Single-Cell Transcriptomics Applied to Embryonic Stem Cells , 2015, Cell.

[6]  M. Junttila,et al.  Translational value of mouse models in oncology drug development , 2015, Nature Medicine.

[7]  Evan Z. Macosko,et al.  Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets , 2015, Cell.

[8]  X. Zhuang,et al.  Spatially resolved, highly multiplexed RNA profiling in single cells , 2015, Science.

[9]  Aleksandra Markovets,et al.  Acquired EGFR C797S mediates resistance to AZD9291 in advanced non-small cell lung cancer harboring EGFR T790M , 2015, Nature Medicine.

[10]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[11]  Kun Zhang,et al.  Fluorescent in situ sequencing (FISSEQ) of RNA for gene expression profiling in intact cells and tissues , 2015, Nature Protocols.

[12]  H. Ishwaran,et al.  Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer , 2015, Nature.

[13]  S. P. Fodor,et al.  Combinatorial labeling of single cells for gene expression cytometry , 2015, Science.

[14]  N. McGranahan,et al.  Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. , 2015, Cancer cell.

[15]  Siddharth S. Dey,et al.  Integrated genome and transcriptome sequencing from the same cell , 2014, Nature Biotechnology.

[16]  Yang Xie,et al.  A community computational challenge to predict the activity of pairs of compounds , 2014, Nature Biotechnology.

[17]  G. Parker,et al.  Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome , 2014, Clinical Cancer Research.

[18]  C. Caldas,et al.  Cancer Core Europe: a consortium to address the cancer care-cancer research continuum challenge. , 2014, European journal of cancer.

[19]  Mariano J. Alvarez,et al.  Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks , 2014, Cell.

[20]  Sheng Li,et al.  Dynamic evolution of clonal epialleles revealed by methclone , 2014, Genome Biology.

[21]  P. Adusumilli,et al.  Cisplatin-Induced Antitumor Immunomodulation: A Review of Preclinical and Clinical Evidence , 2014, Clinical Cancer Research.

[22]  Sheng Li,et al.  The pivotal regulatory landscape of RNA modifications. , 2014, Annual review of genomics and human genetics.

[23]  J. Buhmann,et al.  Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry , 2014, Nature Methods.

[24]  George M. Church,et al.  Highly Multiplexed Subcellular RNA Sequencing in Situ , 2014, Science.

[25]  J. Wolchok,et al.  Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy , 2014, Science Translational Medicine.

[26]  Sean C. Bendall,et al.  Multiplexed ion beam imaging of human breast tumors , 2014, Nature Medicine.

[27]  Ash A. Alizadeh,et al.  An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage , 2013, Nature Medicine.

[28]  Mikko I. Kettunen,et al.  Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose , 2013, Nature Medicine.

[29]  H. Craighead,et al.  Single-molecule analysis of combinatorial epigenomic states in normal and tumor cells , 2013, Proceedings of the National Academy of Sciences.

[30]  Laura S. Shankman,et al.  Detection of Histone Modifications at Specific Gene Loci in Single Cells in Histological Sections , 2012, Nature Methods.

[31]  Daniel F. Hayes,et al.  Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer , 2013 .

[32]  Michael P Snyder,et al.  Two methods for full-length RNA sequencing for low quantities of cells and single cells , 2012, Proceedings of the National Academy of Sciences.

[33]  K. Polyak,et al.  Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.

[34]  Jedd D. Wolchok,et al.  Immunologic correlates of the abscopal effect in a patient with melanoma. , 2012, The New England journal of medicine.

[35]  C. Iacobuzio-Donahue,et al.  Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies , 2012, Cell.

[36]  S. Horvath,et al.  Global histone modification patterns predict risk of prostate cancer recurrence , 2005, Nature.